Anticoagulation in pregnant women with mechanical heart valve prostheses
S S Meschengieser, C G Fondevila, M T Santarelli, M A Lazzari
Departamento de
Hemostasia y Trombosis, Instituto de Investigaciones Hematológicas
"Mariano R Castex", Academia Nacional de Medicina, Buenos Aires,
Argentina
Correspondence to: Dr S S Meschengieser, Pacheco de Melo 3081, 1425 Buenos Aires, Argentina.
Accepted for publication 26 January 1999
OBJECTIVE
To evaluate
the outcome of pregnancy in women with mechanical heart valve
prostheses in relation to the anticoagulant treatment used in the first
trimester and the incidence of thrombotic and bleeding complications.
METHODS
92 pregnancies
in 59 women were followed between 1986 and 1997. In 31 pregnancies,
oral anticoagulants were discontinued when pregnancy was diagnosed and
subcutaneous heparin was started (12 500 U every 12 hours) adjusted to
prolong the adjusted partial thromboplastin time to twice the control
level. In the second trimester oral anticoagulants were resumed but
changed to heparin again 15 days before the expected delivery date. In
61 pregnancies oral anticoagulants were continued during the first
trimester. The same regimen of heparin was used for delivery.
RESULTS
Abortion or
fetal losses were similar (p = 0.5717) in women exposed to oral
anticoagulants in the first trimester (13/61; 25%) compared with those
who received adjusted subcutaneous heparin (6/31; 19%). Embolic
episodes were more common (p = 0.0029) in women who received heparin
(4.92%) compared with those on oral anticoagulants (0.33%). Embolic
episodes were cerebral and transient. No valve thromboses were
observed. No malformations appeared in the 71 newborns, except for one
case of hydrocephalus. There were no maternal deaths secondary to
thrombotic complications. The only death was the result of major
bleeding after the delivery of a premature stillborn.
CONCLUSIONS
Oral
anticoagulants seem to be safer for the mother than adjusted
subcutaneous heparin. Heparin does not offer a clear advantage over
oral anticoagulation in the pregnancy outcome.
Keywords: pregnancy; oral anticoagulants; heparin; prosthetic valves
© 1999 by Heart
This article has been cited by other articles:
-
James, A. H.
(2009). Venous Thromboembolism in Pregnancy. Arterioscler. Thromb. Vasc. Bio.
29: 326-331
[Abstract] [Full Text] -
Butchart, E. G., Gohlke-Barwolf, C., Antunes, M. J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Iung, B., Bjornstad, H., Leport, C., Hall, R. J.C., Vahanian, A., on behalf of the Working Groups on Valvular Heart,
(2005). Recommendations for the management of patients after heart valve surgery. Eur Heart J
26: 2463-2471
[Abstract] [Full Text] -
Elkayam, U., Singh, H., Irani, A., Akhter, M. W.
(2004). Anticoagulation in Pregnant Women With Prosthetic Heart Valves. J CARDIOVASC PHARMACOL THER
9: 107-115
[Abstract] -
Topol, E. J.
(2003). Anticoagulation With Prosthetic Cardiac Valves. Arch Intern Med
163: 2251-2252
[Full Text] -
Al-Lawati, A. A.M., Venkitraman, M., Al-Delaime, T., Valliathu, J.
(2002). Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. Eur. J. Cardiothorac. Surg.
22: 223-227
[Abstract] [Full Text] -
Oles, D., Berryessa, R., Campbell, K., Bhatti, M. A.
(2001). Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: a case report. Perfusion
16: 159-164
[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
